Cargando…

Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report

INTRODUCTION: The development of factor VIII inhibitors is a serious complication of replacement therapy in patients with congenital hemophilia A. Immune tolerance induction has been accepted as the only clinically proven treatment allowing antigen-specific tolerance to factor VIII. However, some of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubisz, Peter, Plamenova, Ivana, Holly, Pavol, Stasko, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492051/ https://www.ncbi.nlm.nih.gov/pubmed/23057781 http://dx.doi.org/10.1186/1752-1947-6-350

Ejemplares similares

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
por: Skornova, Ingrid, et al.
Publicado: (2021)

Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019)

Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016)

How to keep the factor VIII/von Willebrand factor complex in the circulation
por: Denis, Cécile V., et al.
Publicado: (2021)

Subunit Flexibility of Multimeric von Willebrand Factor/Factor VIII Complexes
por: Parker, Ernest T., et al.
Publicado: (2022)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Conformation of the von Willebrand factor/factor VIII complex in quasi-static flow
por: Parker, Ernest T., et al.
Publicado: (2021)

Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis
por: Tóth, Noémi Klára, et al.
Publicado: (2018)

Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease
por: Lapić, Ivana, et al.
Publicado: (2022)

Cerebral Sinus and Venous Thrombosis Associated with von Willebrand Factor, Independently of Factor VIII
por: Terashima, Mari, et al.
Publicado: (2008)

Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity
por: Hollestelle, Martine J., et al.
Publicado: (2011)

Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability
por: Negreva, Mariya Negrinova, et al.
Publicado: (2020)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
por: Montilla, Marcela, et al.
Publicado: (2022)

Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding
por: Casini, Alessandro, et al.
Publicado: (2023)

Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study
por: Goudemand, Jenny, et al.
Publicado: (2020)

Successful desensitization in a patient with Von Willebrand´s disease and anaphylaxis to factor VIII/VW
por: Olival, Maristela, et al.
Publicado: (2014)

Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease
por: BOUMA, B. N., et al.
Publicado: (1975)

The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial
por: Kovacevic, Katarina D., et al.
Publicado: (2021)

Interaction Between the a3 Region of Factor VIII and the TIL’E’ Domains of the von Willebrand Factor
por: Dagil, Lisbeth, et al.
Publicado: (2019)

ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
por: Escher, R., et al.
Publicado: (2020)

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis
por: Praktiknjo, Michael, et al.
Publicado: (2020)

Circulating active von Willebrand factor and immunoglobulin A nephropathy outcomes
por: Gutiérrez, Eduardo, et al.
Publicado: (2020)

Storage of Factor VIII Variants with Impaired von Willebrand Factor Binding in Weibel-Palade Bodies in Endothelial Cells
por: van den Biggelaar, Maartje, et al.
Publicado: (2011)

Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report
por: Ren, Shou-Chen, et al.
Publicado: (2016)

Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels
por: Kiouptsi, Klytaimnistra, et al.
Publicado: (2017)

D’ domain region Arg782-Cys799 of von Willebrand factor contributes to factor VIII binding
por: Przeradzka, Małgorzata A., et al.
Publicado: (2020)

Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine
por: Lämmle, Bernhard
Publicado: (2021)

The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
por: Pablo-Moreno, Juan A. De, et al.
Publicado: (2022)

Severe Traumatic Brain Injury in a Patient with von Willebrand Disease Type 2A Successfully Treated with Factor VIII/von Willebrand Factor Concentrates: A Case Report
por: Koroki, Takatoshi, et al.
Publicado: (2022)

Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function
Publicado: (1982)

On the Versatility of von Willebrand Factor
por: Rauch, Antoine, et al.
Publicado: (2013)

Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014)

Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non‐severe haemophilia A
por: Rejtő, Judit, et al.
Publicado: (2020)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease
por: Casonato, Alessandra, et al.
Publicado: (2016)

Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
por: Jimenez‐Yuste, Victor, et al.
Publicado: (2021)

Factors VIII and Von Willebrand Levels in Women Undergoing Assisted Reproduction: Are Their Levels Associated with Clinical Pregnancy Outcome?
por: Attanasio, Monica, et al.
Publicado: (2020)

von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model
por: Oleshko, Olga, et al.
Publicado: (2023)

Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease
por: Castaman, Giancarlo
Publicado: (2013)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
por: Manderstedt, Eric, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gt6mdj06tua8ks32fflb9om689